Nanopath Inc
Biotechnology company · Cambridge, Massachusetts, United States
Nanopath Inc is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $5.3 million sold in a notice filed in 2025.
Nanopath at a glance
What does Nanopath do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $5.3 million sold (2025).
Frequently asked questions about Nanopath
Where is Nanopath headquartered?
Nanopath Inc is headquartered in Cambridge, Massachusetts, United States.
What does Nanopath do?
Nanopath Inc is a biotechnology company.
When was Nanopath founded?
The earliest incorporation on record for Nanopath Inc is in 2019, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Beam Therapeutics Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences